Shandong Boan Biotechnology Co (HKSE:06955) Debt-to-Equity : 0.31 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Shandong Boan Biotechnology Co Debt-to-Equity?

Shandong Boan Biotechnology Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$187.5 Mil. Shandong Boan Biotechnology Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$256.5 Mil. Shandong Boan Biotechnology Co's Total Stockholders Equity for the quarter that ended in Dec. 2023 was HK$1,443.6 Mil. Shandong Boan Biotechnology Co's debt to equity for the quarter that ended in Dec. 2023 was 0.31.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Shandong Boan Biotechnology Co's Debt-to-Equity or its related term are showing as below:

HKSE:06955' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.03 Med: 0.19 Max: 0.31
Current: 0.31

During the past 4 years, the highest Debt-to-Equity Ratio of Shandong Boan Biotechnology Co was 0.31. The lowest was 0.03. And the median was 0.19.

HKSE:06955's Debt-to-Equity is ranked worse than
66.2% of 1065 companies
in the Biotechnology industry
Industry Median: 0.14 vs HKSE:06955: 0.31

Shandong Boan Biotechnology Co Debt-to-Equity Historical Data

The historical data trend for Shandong Boan Biotechnology Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Boan Biotechnology Co Debt-to-Equity Chart

Shandong Boan Biotechnology Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

0.03

0.17

0.21

0.31

Shandong Boan Biotechnology Co Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial			0.17	0.19	0.21	0.23	0.31

Competitive Comparison of Shandong Boan Biotechnology Co's Debt-to-Equity

For the Biotechnology subindustry, Shandong Boan Biotechnology Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shandong Boan Biotechnology Co's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shandong Boan Biotechnology Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Shandong Boan Biotechnology Co's Debt-to-Equity falls into.

Shandong Boan Biotechnology Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Shandong Boan Biotechnology Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(187.48	+	256.49)	/	1443.644
	=	0.31

Shandong Boan Biotechnology Co's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(187.48	+	256.49)	/	1443.644
	=	0.31

Shandong Boan Biotechnology Co (HKSE:06955) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Shandong Boan Biotechnology Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Shandong Boan Biotechnology Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Boan Biotechnology Co (HKSE:06955) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shandong Boan Biotechnology Co Ltd (HKSE:06955) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

UJ9:Germany

Address

No. 39 Keji Avenue, High-Tech Industrial Development Zone, Shandong Province, Yantai, CHN

Website

https://www.boan-bio.com

Shandong Boan Biotechnology Co Ltd is a fully integrated biopharmaceutical company. The company is engaged in the development, manufacture, and commercialization of high-quality biologics in China and around the world. It focuses on areas such as oncology, metabolism, autoimmunity, and ophthalmology. Geographically company's revenue is generated from customers located in Mainland China.

Shandong Boan Biotechnology Co (HKSE:06955) Headlines

No Headlines